HLA-DM mediates peptide exchange by interacting transiently and repeatedly with HLA-DR1

Molecular Immunology

Volumn 46, Issue 15, 2009, Pages 3157-3162

  Narayan, Kedar ^a   Su, Katherine W ^a   Chou, Chih Ling ^a   Khoruzhenko, Stanislav ^a   Sadegh Nasseri, Scheherazade ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Antigen presentation; Antigen processing; Diffusion; HLA DM; Kinetics; Peptide; Peptide receptive HLA DR; Superantigen; Surface plasmon resonance; Viscosity

Indexed keywords

HLA DM ANTIGEN; HLA DR1 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN; TOXIC SHOCK SYNDROME TOXIN 1;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BINDING COMPETITION; BINDING KINETICS; BINDING SITE; CONTROLLED STUDY; DISSOCIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; SOLVENT EFFECT; VISCOSITY;

HLA-D ANTIGENS; HLA-DR1 ANTIGEN; HUMANS; PEPTIDES; SUPERANTIGENS;

EID: 68749117718     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.07.001     Document Type: Article

References (32)

1. Blum J.S., and Cresswell P. Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 3975-3979
2. Chou C.L., and Sadegh-Nasseri S. HLA-DM recognizes the flexible conformation of major histocompatibility complex class II. J. Exp. Med. 192 (2000) 1697-1706
3. Cresswell P. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12 (1994) 259-293
4. Denzin L.K., and Cresswell P. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 82 (1995) 155-165
5. Denzin L.K., Hammond C., and Cresswell P. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 184 (1996) 2153-2165
6. Doebele R.C., Busch R., Scott H.M., Pashine A., and Mellins E.D. Determination of the HLA-DM interaction site on HLA-DR molecules. Immunity 13 (2000) 517-527
7. Fung-Leung W.P., Surh C.D., Liljedahl M., Pang J., Leturcq D., Peterson P.A., Webb S.R., and Karlsson L. Antigen presentation and T cell development in H2-M-deficient mice. Science 271 (1996) 1278-1281
8. Grotenbreg G.M., Nicholson M.J., Fowler K.D., Wilbuer K., Octavio L., Yang M., Chakraborty A.K., Ploegh H.L., and Wucherpfennig K.W. Empty class II major histocompatibility complex created by peptide photolysis establishes the role of DM in peptide association. J. Biol. Chem. 282 (2007) 21425-21436
9. Kropshofer H., Arndt S.O., Moldenhauer G., Hammerling G.J., and Vogt A.B. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 6 (1997) 293-302
10. Kropshofer H., Vogt A.B., Moldenhauer G., Hammer J., Blum J.S., and Hammerling G.J. Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J. 15 (1996) 6144-6154
11. McFarland B.J., Katz J.F., Beeson C., and Sant A.J. Energetic asymmetry among hydrogen bonds in MHC class II*peptide complexes. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 9231-9236
12. McNally J.G., Muller W.G., Walker D., Wolford R., and Hager G.L. The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science 287 (2000) 1262-1265
13. Narayan K., Chou C.L., Kim A., Hartman I.Z., Dalai S., Khoruzhenko S., and Sadegh-Nasseri S. HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes. Nat. Immunol. 8 (2007) 92-100
14. Natarajan S.K., Assadi M., and Sadegh-Nasseri S. Stable peptide binding to MHC class II molecule is rapid and is determined by a receptive conformation shaped by prior association with low affinity peptides. J. Immunol. 162 (1999) 4030-4036
15. Natarajan S.K., Stern L.J., and Sadegh-Nasseri S. Sodium dodecyl sulfate stability of HLA-DR1 complexes correlates with burial of hydrophobic residues in pocket 1. J. Immunol. 162 (1999) 3463-3470
16. Papageorgiou A.C., and Acharya K.R. Microbial superantigens: from structure to function. Trends Microbiol. 8 (2000) 369-375
17. Pashine A., Busch R., Belmares M.P., Munning J.N., Doebele R.C., Buckingham M., Nolan G.P., and Mellins E.D. Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides. Immunity 19 (2003) 183-192
18. Peters P.J., Neefjes J.J., Oorschot V., Ploegh H.L., and Geuze H.J. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 349 (1991) 669-676
19. Proft T., and Fraser J.D. Bacterial superantigens. Clin. Exp. Immunol. 133 (2003) 299-306
20. Rabinowitz J.D., Vrljic M., Kasson P.M., Liang M.N., Busch R., Boniface J.J., Davis M.M., and McConnell H.M. Formation of a highly peptide-receptive state of class II MHC. Immunity 9 (1998) 699-709
21. Rigaud G., Roux J., Pictet R., and Grange T. In vivo footprinting of rat TAT gene: dynamic interplay between the glucocorticoid receptor and a liver-specific factor. Cell 67 (1991) 977-986
22. Sadegh-Nasseri S., Chen M., Narayan K., and Bouvier M. The convergent roles of tapasin and HLA-DM in antigen presentation. Trends Immunol. 29 (2008) 141-147
23. Sadegh-Nasseri S., and McConnell H.M. A kinetic intermediate in the reaction of an antigenic peptide and I-Ek. Nature 337 (1989) 274-276
24. Stern L.J., Brown J.H., Jardetzky T.S., Gorga J.C., Urban R.G., Strominger J.L., and Wiley D.C. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368 (1994) 215-221
25. Thibodeau J., Lavoie P.M., and Cazenave P.A. "Bazinc" instinct: how SEA attracts MHC class II molecules. Res. Immunol. 148 (1997) 217-229
26. Ullrich H.J., Doring K., Gruneberg U., Jahnig F., Trowsdale J., and van Ham S.M. Interaction between HLA-DM and HLA-DR involves regions that undergo conformational changes at lysosomal pH. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 13163-13168
27. Ulrich R.G., Olson M.A., and Bavari S. Development of engineered vaccines effective against structurally related bacterial superantigens. Vaccine 16 (1998) 1857-1864
28. Vogt A.B., Kropshofer H., Moldenhauer G., and Hammerling G.J. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 9724-9729
29. Weber D.A., Dao C.T., Jun J., Wigal J.L., and Jensen P.E. Transmembrane domain-mediated colocalization of HLA-DM and HLA-DR is required for optimal HLA-DM catalytic activity. J. Immunol. 167 (2001) 5167-5174
30. Weber D.A., Evavold B.D., and Jensen P.E. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 274 (1996) 618-620
31. Zarutskie J.A., Busch R., Zavala-Ruiz Z., Rushe M., Mellins E.D., and Stern L.J. The kinetic basis of peptide exchange catalysis by HLA-DM. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 12450-12455
32. Zwart W., Griekspoor A., Kuijl C., Marsman M., van Rheenen J., Janssen H., Calafat J., van Ham M., Janssen L., van Lith M., Jalink K., and Neefjes J. Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape. Immunity 22 (2005) 221-233